Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • AMYLIN PHARMACEUTICALS INC Financial Overview

  • Income Statement: AMLN

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 840.11 M 781.00 M 59.11 M 7.04%
    Gross Profit 748.51 M 715.54 M 32.97 M 4.41%
    Net Income Before Extra Items/Preferred Div -315.40 M -211.14 M -104.27 M 33.06%
    Operating Income -242.29 M -242.98 M 682,000.00 -0.28%
  • Cash Flow: AMLN

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 16.69 M 776.85 M -760.16 M -4,553.49%
    Net Cash Flow - Investing 182.15 M 296.10 M -113.95 M -62.56%
    Net Cash Flow/Operating Activities -19.51 M -125.16 M 105.65 M -541.52%
  • Balance Sheet: AMLN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 1.71 B 1.77 B -61.58 M -3.60%
    Total Liabilities 1.36 B 1.22 B 140.36 M 10.31%
    Shareholders Equity 350.87 M 552.82 M -201.94 M -57.55%
  • Key Ratios / Statistics: AMLN

    • Valuation

      Price/Earnings (TTM) -4.72
      Price/Sales (TTM) 1.77
      Price/Book (MRQ) 4.05
      Price/Cash Flow (TTM) -20.14
    • Profitability

      Gross Margin 89.10
      Operating Margin -28.84
      Profit Margin -37.54
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.81
      Current Ratio (MRQ) 3.15
      Long Term Debt-to-Equity (MRQ) 153.08
    • Management Effectiveness

      Return on Equity (TTM) -69.24
      Return on Assets (TTM) -16.17
      Return on Investments (TTM) -21.90